Psychae Therapeutics: Funding, Investors & Team (Sep 2026)
We develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses
Psychae Therapeutics has raised $2.9M across 1 funding round on record, the most recent a Pre-Seed of $2.9M announced in Nov 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Psychae Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Psychae Therapeutics Funding Rounds
Psychae Therapeutics Founders and Leadership Team
Contact details for the Psychae Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Psychae Therapeutics Funding Compared to Other Biotechnology Startups
Psychae Therapeutics' latest round of $2.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Psychae Therapeutics in Biotechnology and Carlton
Companies Similar to Psychae Therapeutics
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Psychae Therapeutics Funding FAQs
What does Psychae Therapeutics do?
We develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses
How much funding has Psychae Therapeutics raised?
Psychae Therapeutics has raised $2.9M across 1 round on record. The most recent is a Pre-Seed of $2.9M announced in Nov 2023.
When did Psychae Therapeutics last raise funding?
Psychae Therapeutics' most recent funding round on record is a Pre-Seed of $2.9M, announced in Nov 2023.
Who is the CEO of Psychae Therapeutics?
Daniel Perkins is listed as CEO at Psychae Therapeutics.
Where is Psychae Therapeutics headquartered?
Psychae Therapeutics is based in Carlton, Victoria, Australia.
How many employees does Psychae Therapeutics have?
Psychae Therapeutics is in the 1-10 employee band.
How does Psychae Therapeutics' funding compare to other Biotechnology startups?
Psychae Therapeutics' latest round of $2.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Psychae Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Psychae Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.